Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus: A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study).

Masahiro FukudaIchiro SakumaYutaka WakasaHideaki FunayamaAkira KondoNaoki ItabashiYasuyuki MaruyamaTakashi KamiyamaYasunori UtsunomiyaAkira YamauchiHidenori YoshiiHirokazu YamadaKoichi MochizukiMasahiro Sugawaranull null

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)

UMIN000030128 and jRCTs031180241.

Keyphrases

randomized controlled trial
open label
end stage renal disease
study protocol
ejection fraction
newly diagnosed
chronic kidney disease
clinical trial
prognostic factors
systematic review
radiation therapy
squamous cell carcinoma
cross sectional
phase ii
combination therapy
replacement therapy
phase iii